Clinical Trial Update: Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result [NA]

View source ↗

Summary

A completed clinical evaluation of the PROGENSA PCA3 diagnostic assay in men with a prior negative prostate biopsy to assess its role in detecting prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PROGENSA PCA3 Assay

Snippet

Sponsor: Gen-Probe, Incorporated | Conditions: Prostatic Neoplasms | NA | Status: COMPLETED | Results posted: 2012-11-07